- Trials with a EudraCT protocol (44)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44 result(s) found for: Brachytherapy.
Displaying page 1 of 3.
EudraCT Number: 2008-002985-70 | Sponsor Protocol Number: MD-R20080507 | Start Date*: 2009-04-23 |
Sponsor Name:University of Magdeburg | ||
Full Title: Evaluation of the preventive effect of pentoxifylline and ursodeoxycholic acid to radiation induced liver toxicity after brachytherapy of liver metastases, assessed in a prospective randomised trial. | ||
Medical condition: Irradiation damage to the liver after HDR-brachytherapy of liver metastases. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004119-36 | Sponsor Protocol Number: METOXY-LACC | Start Date*: 2019-11-04 | |||||||||||
Sponsor Name:Oslo University Hospital | |||||||||||||
Full Title: Altered tumor oxygenation by Metformin, a potential step in overcoming radiotherapy resistance in locally advanced cervical cancer. | |||||||||||||
Medical condition: Locally advanced cervical cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002251-33 | Sponsor Protocol Number: 01 | Start Date*: 2006-10-10 |
Sponsor Name:University of Vienna | ||
Full Title: Hypoxia Imaging with the novel Radiopharmaceutical 18F Fluoroazomycin Arabinoside (FAZA)- Prognostic impact in Cervical Cancer . | ||
Medical condition: Twenty-five patients with cervical carcinoma (T2Nx or TxN1) will be included in the present study. In addition to the routine pre-therapeutical staging of cervical cancer, 18FAZA PET will be perfor... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012509-20 | Sponsor Protocol Number: MERLOT | Start Date*: 2009-07-28 | |||||||||||
Sponsor Name:King's College Hospital NHS Foundation Trust | |||||||||||||
Full Title: A randomised controlled trial of epimacular brachytherapy versus ranibizumab monotherapy for the treatment of subfoveal choroidal neovascularisation associated with wet age-related macular degenera... | |||||||||||||
Medical condition: Wet age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000808-40 | Sponsor Protocol Number: 2004-27-IMP-2 | Start Date*: 2005-01-13 |
Sponsor Name:Hexal AG | ||
Full Title: Randomized, open label, multi-center, phase III study on pharmacokinetics, pharmacodynamics, efficacy and safety of Goserelin 1M Implant HEXAL in patients with advanced prostatic cancer in comparis... | ||
Medical condition: Palliative treatment of advanced prostatic cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: LT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002873-62 | Sponsor Protocol Number: 2005-34-IMP-2 | Start Date*: 2006-02-15 |
Sponsor Name:HEXAL AG | ||
Full Title: RANDOMIZED, OPEN LABEL, MULTICENTER, PHASE II STUDY ON PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY AND SAFETY OF BUSERELIN 3M IMPLANT HEXAL IN PATIENTS WITH ADVANCED PROSTATIC CANCER IN COMPARISON... | ||
Medical condition: Palliative treatment of advanced prostatic cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001279-36 | Sponsor Protocol Number: 2005-01-IMP-2 | Start Date*: 2005-08-24 |
Sponsor Name:Hexal AG | ||
Full Title: RANDOMIZED, OPEN LABEL, MULTICENTER, PHASE II STUDY ON PHARMACOKINETICS, PHARMACODYNAMICS, EFFICACY AND SAFETY OF GOSERELIN 3M IMPLANT HEXAL IN PATIENTS WITH ADVANCED PROSTATIC CANCER IN COMPARISON... | ||
Medical condition: Palliative treatment of advanced prostatic cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: LT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002251-41 | Sponsor Protocol Number: RE 001-2005 | Start Date*: 2005-03-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA | |||||||||||||
Full Title: ASTRA STUDY (Angioplasty, Stent X-ray Intensive Antithrombotic Therapy) A PHASE III, PROSPECTIVE AND RANDOMIZED, MULTICENTER STUDY, OPEN LABEL, PARALLEL-GROUP, BLINDED ADJUDICATION, TO INVESTIGATE ... | |||||||||||||
Medical condition: PAOD (Fontaine-Leriche St. IIb-IV)requiring percutaneous angioplasty with or without stenting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001381-42 | Sponsor Protocol Number: IMMULAB | Start Date*: 2019-01-25 | |||||||||||
Sponsor Name:Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus Nordwest | |||||||||||||
Full Title: IMMULAB – A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC) | |||||||||||||
Medical condition: early stage hepatocellular carcinoma (HCC) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002675-34 | Sponsor Protocol Number: NL40235.078.12 | Start Date*: 2012-09-12 |
Sponsor Name: | ||
Full Title: Surgical and aesthetic outcome, quality of life, and cost-effectiveness of keloid treatment | ||
Medical condition: Keloid | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004749-41 | Sponsor Protocol Number: NEO-ONE | Start Date*: 2011-12-13 | |||||||||||
Sponsor Name:TweeSteden hospital | |||||||||||||
Full Title: The effects of neoadjuvant hormonal therapy on the course of PSA and testosterone in patients with low and intermediate-risk prostate carcinoma (NEO-ONE); A randomized controlled trial | |||||||||||||
Medical condition: Localized prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000625-37 | Sponsor Protocol Number: BED-004 | Start Date*: 2015-08-28 | |||||||||||
Sponsor Name:Blue Earth Diagnostics Limited | |||||||||||||
Full Title: A phase 3, open-label study to assess the clinical utility of fluciclovine (18F) PET/CT in patients with prostate cancer with biochemical recurrence after radical treatment | |||||||||||||
Medical condition: Prostate cancer with biochemical recurrence after radical treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017798-39 | Sponsor Protocol Number: PROVAX study | Start Date*: 2010-07-08 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: An open label, Phase II study of vaccination with Survivin peptides emulsified in Montanide ISA 51VG after IMP 321 injection in prostate carcinoma patients with biochemical failure (PROVAX study) | |||||||||||||
Medical condition: Prostate cancer, biochemical failure after all potentially curative standard local therapies (radiotherapy, brachytherapy and surgery) or biochemical progression while patients have castrated level... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003873-41 | Sponsor Protocol Number: 14-23-16/07 | Start Date*: 2015-07-09 |
Sponsor Name:MAASTRO Clinic | ||
Full Title: Non invasive imaging of tumor hypoxia with [18F]HX4 Positron-Emission-Tomography (PET): A phase II trial | ||
Medical condition: Eligible patients with histologically/cytologically proven primary tumors of the prostate, esophagus, brain or rectum or metastatic disease to the brain (originating from breast, lung or colorectal... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004397-99 | Sponsor Protocol Number: MBCC28040 | Start Date*: 2014-06-17 |
Sponsor Name:Instituto Tecnológico PET, S.A.U. (ITP) | ||
Full Title: A Phase III Clinical Trial to evidence the safety and efficacy of the radio-drug 18f-Fluorocholine (18F-FCH), using Positron Emission Tomography (PET) for the diagnosis of the prostate carcinoma in... | ||
Medical condition: Prostate Carcinoma in patients with biochemical relapse. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-020480-21 | Sponsor Protocol Number: pro-duct001 | Start Date*: 2010-11-18 |
Sponsor Name:Universitätsmedizin Charite | ||
Full Title: Feasibility and efficacy of adjuvant gemcitabine chemotherapy after liver transplantation for proximal bile duct cancer | ||
Medical condition: proximal bile duct cancer | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003382-18 | Sponsor Protocol Number: BED-PSMA-302 | Start Date*: 2020-05-25 | |||||||||||
Sponsor Name:Blue Earth Diagnostics Ireland Ltd. | |||||||||||||
Full Title: A prospective, Phase 3, multi-center, single-arm, imaging study investigating the safety and diagnostic performance of rhPSMA-7.3 (18F) PET ligand in men with suspected prostate cancer recurrence b... | |||||||||||||
Medical condition: Prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FI (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003622-33 | Sponsor Protocol Number: 2017/2608 | Start Date*: 2018-04-03 | ||||||||||||||||
Sponsor Name:Gustave Roussy | ||||||||||||||||||
Full Title: Randomized Phase II Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab in Locally Advanced Cervical Cancer | ||||||||||||||||||
Medical condition: Locally Advanced Cervical Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001128-31 | Sponsor Protocol Number: 13-23 | Start Date*: 2014-09-23 | |||||||||||
Sponsor Name:Cancer Trials Ireland | |||||||||||||
Full Title: Phase II Single-arm Study evaluating Neo-adjuvant (pre-radical radiotherapy) Abiraterone acetate (plus prednisolone) and Gonadotropin-Releasing Hormone (GnRH) agonist in high risk localised prostat... | |||||||||||||
Medical condition: High-risk prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001200-20 | Sponsor Protocol Number: CSET 1287 | Start Date*: 2007-06-01 |
Sponsor Name:Institut Gustave Roussy | ||
Full Title: A Multicenter, Randomized Phase II Trial Assessing the Activity of Gemcitabine – Oxaliplatin Chemotherapy Alone or in Combination with Cetuximab in Patients with Advanced Biliary Cancer | ||
Medical condition: adenocarcinoma of the biliary tract ( gallbladder, intra and/ or extrahepatic bile ducts, ampulla of Vater) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) DE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.